Dr. Andrea Lisotti

University of Bologna, Italy

Email: lisotti.andrea@gmail.com

Qualifications

2010 I Level Master in Science – Clinical Nutrition and Functional Foods

2008 Italian Medical License

2007 Degree in Medicine – University of Bologna

Publications (Selected)

1. Azzaroli F., Turco L., Lisotti A., Cecinato P., Calvanese C., Buonfiglioli F., Cevenini M, Montagnani M, Mazzella G. Alisporivir for the treatment of chronic HCV. Future virology 2012; 7(1); 9-18.
2. Montagnani M, Giandinoto M, Lisotti A, Galli S, Azzaroli F, Buonfiglioli F, Turco L, Aldini R, Mazzella G. High Dose Lamivudine in HBV-Related Cirrhotic Patients with Unsatisfactory Response After Adefovir Add-On. Dig Dis Sci. 2012 Feb;57(2):561-7.
3. Lisotti A, Azzaroli F, Brillanti S, Mazzella G. Severe acute autoimmune hepatitis after natalizumab treatment. Dig Liver Dis. 2011 Dec 9. [Epub ahead of print]
4. Azzaroli F, Turco L, Lisotti A, Calvanese C, Mazzella G. The pharmacological management of intrahepatic cholestasis of pregnancy. Curr Clin Pharmacol. 2011 Feb;6(1):12-7.
5. Lisotti A., Cornia GL., Morselli-Labate A.M., Sartini A., Turco L., Grasso V., Cavina P., Mazzella G., Roda E. Effects of a fermented milk containingKluyveromyces marxianus B0399 and Bifidobacterium lactis BB12 in patients with irritable bowel syndrome. Minerva Gastroenterol Dietol 2011;57(Suppl. 1 al N.2): 1-12.
6. Lisotti A, Roda G, Brillanti S, Roda E. Reactivation of Crohn's disease after pandemic aH1N1 and seasonal flu vaccinations. Dig Liver Dis. 2010 Dec;42(12):909-10.
7. Caponi A, Lisotti A, Grenci C, Roda E. Are therapeutic doses of ursodeoxycholic acid in the cure of primary biliary cirrhosis inadequate? Some clinical considerations. Minerva Gastroenterol Dietol. 2008 Dec;54(4):331-4.
8. Lisotti A, Grenci C, Caponi A, Roda E. The management of NSAIDs therapy: how to minimize upper gastrointestinal tract damage. Minerva Gastroenterol Dietol. 2008 Dec;54(4):323-9.
9. Lisotti A, Azzaroli F, Buonfiglioli F, Montagnani M, Alessandrelli F, Mazzella G. Lamivudine treatment for severe acute HBV hepatitis. Int J Med Sci. 2008;5(6):309-12.
10. Lisotti A, Grenci C, Caponi A, Roda E. Chronic hepatitis B in 2008. Dig Liv Dis Supplements 2008; suppl 2; 3-6.
11. Azzaroli F., Lisotti A., Calvanese C., Turco L. and Mazzella G. Chronic NSAIDs therapy and upper gastrointestinal tract: mechanism of injury, mucosl defense, risk factors for complications development and clinical management. Book Chapter in “Gastroenterology” ISBN 979-953-307-495-4. Accepted for publication.
12. Grenci C, Lisotti A, Caponi A, Roda E. Obesity: Risk factor for GI disease? Elisir di salute 2008; 5; 10-13.
13. Grenci C, Lisotti A, Caponi A, Roda E. Obesity: epidemiology and social impact. The gastroenterologist 2008, 2; 41-3.
14. Grenci C, Lisotti A, Caponi A, Roda E. Le tante facce della malattia celiaca – un case report. Rivista SIMG 2008 Sep; 4; 59-61.